19-10-2021, 10:46 PM
Shares of Valneva soared 35% in premarket trading on Monday. The specialty vaccine company reported highly encouraging results for its COVID-19 vaccine candidate, and shareholders are excited about what that could mean for Valneva's future.
https://www.fool.com/investing/2021/10/1...re-market/
https://www.fool.com/investing/2021/10/1...re-market/